ANTI-SNORING TREATMENT MARKET ANALYSIS

Snoring is the vibration of respiratory structures which results in sound while sleeping. It is a sleeping disorder caused due to monotonous narrowing and collapsing of the upper airway. Snoring have various adverse effects on health include coronary artery disease, systemic hypertension, atrial fibrillation, and stroke. Snoring is one of the factors of sleep deprivation, which may be further caused due to throat weakness, mispositioned jaw, obesity, and obstruction in the nasal passageway due to intake of alcohol and drugs. Snoring is a general phenomenon which can be treated or cured by use of anti-snoring devices or by nasal surgery. More than 300 devices are registered in the U.S. Patent and Trademark Office to cure snoring. However, surgery for the treatment of snoring include Laser-assisted uvulopalatoplasty, Uvulopalatopharyngoplasty, Radiofrequency ablation, sclerotherapy, Pillar procedure and others.

High intake of alcohol and drugs is major cause of snoring, which is expected to augment the market growth

According to World Drug Report 2016, drug intake has reached epidemic levels with around 247 million drug users worldwide. Snoring is mainly caused due to intake of alcohol and drugs, which relax throat muscles. Moreover, increased consumption of alcohol by an individual for over a period of time causes respiratory tract blockage and also obesity is a major concern, leading to soring. According to World Health Organization (WHO), in 2014, around 1.9 billion adults were reported to have overweight, from which over 600 million adults were obese. Obesity is the second most common factor which results in snoring, it causes accumulation of fat around throat which causes increase in the prevalence of respiratory tract blockage. The removal of fat can be obtained by the laser-assisted surgeries, which in turn is expected to augment the market growth in the near future. Lack of knowledge about proper treatment and high cost of anti-snoring devices and surgeries are some of the factors restraining the anti-snoring treatment market growth.

Anti-Snoring Treatment-Market Taxonomy

The anti-snoring treatment market is segmented on the basis of anti-snoring devices and end user

On the basis of surgery, the global anti-snoring treatment market is segmented into:

• Nasal devices
• Chin straps
• Oral appliances,
• Position control devices
• Tongue stabilizing devices
• Expiratory positive airway pressure therapy devices.

On the basis of end user, the global anti-snoring treatment market is segment into:

• Hospital
• Clinics
• Ambulatory Surgical Centers/ Day Care Centers
• Others

Increasing prevalence of diabetes and alcohol consumption is expected to propel the market growth

Regional segmentation of the anti-snoring treatment market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold the dominant position in the anti-snoring treatment market, due to the increasing prevalence of snoring disorder in region. According to American Sleep Foundation, in 2017, around 90 million American of all age group and genders are affected from one or the other respiratory disorder leading to snoring leading to increasing prevalence of snoring, expected to increase the demand for its treatment and hence fueling anti-snoring treatment market. Asia Pacific is expected to be the next dominant market, due to increasing obesity and respiratory disorders, leading to propel the growth of the anti-snoring treatment market over the forecast period.

Market Players

Some of the major players operating in the global anti-snoring treatment market include GlaxoSmithKline, plc, Apnea Sciences Corporation, Fisher & Paykel Healthcare, Sleeping Well, LLC, Sleep Well Enjoy Life, Ltd., AccuMED Corp., ResMed, Inc., and Airing CPAP.